Introduction Of Cervical Cancer Vaccine Delayed

The South Korean authorities have pushed back a decision to include MSD Korea's cervical cancer vaccine, Gardasil, in the national immunisation programme. BMI believes the development is a blow to the manufacturer as it allows GlaxoSmithKline Korea's rival preventative, Cervarix, an opportunity to compete for the lucrative

To read the full article, please choose one of the following options: